AU Patent

AU2015266453C1 — Alk kinase inhibitor, and preparation method and use thereof

Assigned to Shanghai Emerald Wellcares Pharmaceutical Co Ltd · Expires 2018-09-13 · 8y expired

What this patent protects

An ALK kinase inhibitor compound as represented by formula I, pharmaceutical composition containing the compound, and preparation method and use thereof in the preparation of drugs serving as an ALK inhibitor for treating cancer.

USPTO Abstract

An ALK kinase inhibitor compound as represented by formula I, pharmaceutical composition containing the compound, and preparation method and use thereof in the preparation of drugs serving as an ALK inhibitor for treating cancer.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015266453C1
Jurisdiction
AU
Classification
—
Expires
2018-09-13
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Emerald Wellcares Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.